Integrated Intervention for Breast Cancer Survivors With Diabetes

Completed · Not applicable

Conditions studied: Diabetes, Breast Cancer

In brief

The purpose of this research study is to learn how therapy for breast cancer or DCIS/LCIS affects cognitive function and beliefs about cancer/DCIS/LCIS and diabetes (DM). For this portion of the study, the study team will integrate the information collected at previous follow-ups to create educational modules to change disease and medication beliefs and improve DM self-management behaviors (SMB). The educational counseling modules the study team plans to pilot test are rooted in the Common Sense Self-Regulation Model, a theory that posits that health behaviors are influenced by two parallel processes: cognitive (i.e., disease beliefs and expectations) and affective (i.e., emotional responses).

Key facts

Study ID

NCT05092477

Run by

Icahn School of Medicine at Mount Sinai

People needed

59

Starts

2022-01-27

Expected to finish

2023-07-24

Last updated by the study team

2023-10-23

Who can join

Age: 55 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• An enrolled participant in the main observational study
• Completed 18-month follow-up interview
• Have at least 1 SMB target (Scored less than scored <4.5 on the MARS for DM, and/or <80% on objective adherence at 12-month (DM), and/or scored <7 on SDSCA)
• Must be willing to participate in the pilot intervention

You may not qualify if…

• Participant with suspected clinical depression on CESD (scored ≥20)

Where it is running

• Feinberg School of Medicine — Chicago, Illinois, United States
• Northwell Health — New Hyde Park, New York, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.